This chapter explores treatment protocols for low platelet counts in patients with immune thrombocytopenic purpura (ITP), emphasizing the importance of monitoring and adapting individual treatment plans. The discussion covers advancements beyond corticosteroids, including thrombopoietin receptor agonists, and addresses the long-term complications associated with ITP management. Additionally, disparities in healthcare access and the significance of education in improving ITP treatment outcomes are highlighted.